Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart C Jacobs

Showing results (71-80 of 222) with videos related to

Pageof 23
Sort By:
Muscle & Nerve|April 5, 2002
Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barré syndromeBart C Jacobs, Roland W M Bullens, Graham M O'Hanlon, et al.
JAMA Neurology|December 28, 2016
Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barré SyndromeWillem-Jan R Fokkink, Christa Walgaard, Krista Kuitwaard, et al.
Journal of Neuroimmunology|April 15, 2004
Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patientsKarin Geleijns, Bart C Jacobs, Wouter Van Rijs, et al.
Journal of Neuroimmunology|January 8, 2008
Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndromeBart C Jacobs, Michiaki Koga, Wouter van Rijs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2013
Hepatitis E and Guillain-Barre syndromeCorine H Geurtsvankessel, Zhahirul Islam, Quazi D Mohammad, et al.
Annals of Clinical and Translational Neurology|July 31, 2022
Validation and adjustment of modified Erasmus GBS outcome score in BangladeshNowshin Papri, Alex Y Doets, Quazi D Mohammad, et al.
Emerging Infectious Diseases|September 16, 2009
Campylobacter jejuni HS:23 and Guillain-Barre syndrome, BangladeshZhahirul Islam, Alex van Belkum, Alison J Cody, et al.
Neurocritical Care|August 20, 2016
Tracheostomy or Not: Prediction of Prolonged Mechanical Ventilation in Guillain-Barré SyndromeChrista Walgaard, Hester F Lingsma, Pieter A van Doorn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2013
Sialylation of Campylobacter jejuni endotoxin promotes dendritic cell-mediated B cell responses through CD14-dependent production of IFN-β and TNF-αRuth Huizinga, Wouter van Rijs, Jeffrey J Bajramovic, et al.
The Lancet. Neurology|June 1, 2007
A clinical prognostic scoring system for Guillain-Barré syndromeRinske van Koningsveld, Ewout W Steyerberg, Richard A C Hughes, et al.
Pageof 23

Showing results (71-80 of 222) with videos related to

Sort By:
Pageof 23
Muscle & Nerve|April 5, 2002
Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barré syndromeBart C Jacobs, Roland W M Bullens, Graham M O'Hanlon, et al.
JAMA Neurology|December 28, 2016
Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barré SyndromeWillem-Jan R Fokkink, Christa Walgaard, Krista Kuitwaard, et al.
Journal of Neuroimmunology|April 15, 2004
Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patientsKarin Geleijns, Bart C Jacobs, Wouter Van Rijs, et al.
Journal of Neuroimmunology|January 8, 2008
Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndromeBart C Jacobs, Michiaki Koga, Wouter van Rijs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2013
Hepatitis E and Guillain-Barre syndromeCorine H Geurtsvankessel, Zhahirul Islam, Quazi D Mohammad, et al.
Annals of Clinical and Translational Neurology|July 31, 2022
Validation and adjustment of modified Erasmus GBS outcome score in BangladeshNowshin Papri, Alex Y Doets, Quazi D Mohammad, et al.
Emerging Infectious Diseases|September 16, 2009
Campylobacter jejuni HS:23 and Guillain-Barre syndrome, BangladeshZhahirul Islam, Alex van Belkum, Alison J Cody, et al.
Neurocritical Care|August 20, 2016
Tracheostomy or Not: Prediction of Prolonged Mechanical Ventilation in Guillain-Barré SyndromeChrista Walgaard, Hester F Lingsma, Pieter A van Doorn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2013
Sialylation of Campylobacter jejuni endotoxin promotes dendritic cell-mediated B cell responses through CD14-dependent production of IFN-β and TNF-αRuth Huizinga, Wouter van Rijs, Jeffrey J Bajramovic, et al.
The Lancet. Neurology|June 1, 2007
A clinical prognostic scoring system for Guillain-Barré syndromeRinske van Koningsveld, Ewout W Steyerberg, Richard A C Hughes, et al.
Pageof 23